{"id":2390,"date":"2025-01-16T13:22:01","date_gmt":"2025-01-16T10:22:01","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2390"},"modified":"2025-01-16T13:22:02","modified_gmt":"2025-01-16T10:22:02","slug":"insmeds-gene-therapy-ins1201-poised-to-challenge-duchenne-muscular-dystrophy-dmd","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/tr\/insmeds-gene-therapy-ins1201-poised-to-challenge-duchenne-muscular-dystrophy-dmd\/","title":{"rendered":"Insmed'in Gen Terapisi (INS1201) Duchenne Kas Distrofisi'ne (DMD) Meydan Okumaya Haz\u0131r"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Insmed, Duchenne kas distrofisiyle m\u00fccadele etmek i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an gen terapisi INS1201&#039;i kullanmaya haz\u0131rlan\u0131yor. Insmed, FDA&#039;nin Aral\u0131k 2024&#039;te ara\u015ft\u0131rma ama\u00e7l\u0131 yeni ila\u00e7 (IND) ba\u015fvurusunu onaylamas\u0131n\u0131n ard\u0131ndan 2025&#039;in ilk yar\u0131s\u0131nda INS1201 i\u00e7in Faz I klinik \u00e7al\u0131\u015fmalar\u0131na ba\u015flamay\u0131 planl\u0131yor.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Insmed INS1201 Gen Terapisi Nedir?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">INS1201, sistemik intraven\u00f6z enjeksiyon gerektiren Elevidys&#039;nin aksine, merkezi sinir sistemini do\u011frudan hedef al\u0131r ve intratekal olarak uygulan\u0131r. Sistemik gen tedavilerindeki g\u00fcvenlik ve etkinlik sorunlar\u0131n\u0131n bu odaklanm\u0131\u015f uygulama stratejisiyle ele al\u0131nmas\u0131 ama\u00e7lanmaktad\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u0130ntratekal uygulama, gerekli dozu on ila elli kata kadar \u00f6nemli \u00f6l\u00e7\u00fcde d\u00fc\u015f\u00fcr\u00fcr, ilac\u0131 ihtiya\u00e7 duyulan yere yo\u011funla\u015ft\u0131rarak sistemik toksisiteyi ve hedef d\u0131\u015f\u0131 etkileri \u00f6nler. Omurilik yaralanmas\u0131, sinir hasar\u0131 ve enfeksiyon riski gibi engellere ra\u011fmen, bu hastalara daha g\u00fcvenli ve muhtemelen daha ba\u015far\u0131l\u0131 bir se\u00e7enek sa\u011flayabilir, \u00f6zellikle de intraven\u00f6z tedavide kullan\u0131lan b\u00fcy\u00fck viral vekt\u00f6r dozajlar\u0131yla ili\u015fkili g\u00fcvenlik sorunlar\u0131 \u0131\u015f\u0131\u011f\u0131nda.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Daha fazla bilgi edin:<\/strong> <a href=\"https:\/\/dmdwarrior.com\/tr\/new-gene-therapies-for-duchenne-muscular-dystrophy\/\" target=\"_blank\" rel=\"noreferrer noopener\">Duchenne Musk\u00fcler Distrofisi \u0130\u00e7in Umut Veren Yeni Gen Terapileri<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Insmed is getting ready to use its ground-breaking gene therapy, INS1201, to combat Duchenne muscular dystrophy. Insmed intends to start Phase I clinical trials for INS1201 in the first half of 2025 after the FDA approved its investigational new drug (IND) application in December 2024. What is Insmed INS1201 Gene Therapy? INS1201 targets the central [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2465,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[66,72,61,173,174,172],"class_list":["post-2390","post","type-post","status-publish","format-standard","has-post-thumbnail","category-research","tag-duchenne-muscular-dystrophy","tag-gene-editing","tag-gene-therapy","tag-ins1201","tag-ins1201-gene-therapy","tag-insmed"],"subtitle":"Insmed, INS1201 Duchenne (DMD) gen terapisi i\u00e7in 2025 y\u0131l\u0131n\u0131n ilk yar\u0131s\u0131nda Faz I klinik \u00e7al\u0131\u015fmalar\u0131na ba\u015flamay\u0131 planl\u0131yor.","_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/2390","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/comments?post=2390"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/2390\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media\/2465"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media?parent=2390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/categories?post=2390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/tags?post=2390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}